Can You Take Akkermansia With Other Probiotics? How to Combine Products Safely
Quick Answer:
For a generally healthy adult, taking an Akkermansia supplement alongside another probiotic is not automatically a problem. What the research does not show is that stacking two separate products works better, or is safer, than one well-matched formula. The decision rests on the complete label of each product: which strains it contains, whether they are live or inactivated, and which fibers, botanicals and sweeteners appear twice. If you manage a medical condition or take prescription medicines, ask your clinician first.
If you already take a probiotic and are thinking about adding Akkermansia, the real question is less about two bacteria getting along and more about two complete products. Very few gut-health supplements contain a single organism anymore. One bottle may hold live strains, inactivated microbes, fiber, plant extracts and sweeteners, so combining two products means combining everything printed on both labels.
How Is Akkermansia Different From the Probiotics Most People Already Take?
The probiotics most people have tried are strains of Lactobacillus (a group scientists have since divided into several new genera) and Bifidobacterium, along with the probiotic yeast Saccharomyces boulardii. Akkermansia muciniphila is a different kind of organism. It lives in the layer of mucus that lines the intestine and uses mucin, the main protein in that mucus, as a food source. Researchers study it mainly for its links to gut-barrier function and metabolic health.
Two details on any label matter more than the word "Akkermansia" itself.
-
Whether the organism is alive. By scientific definition, a probiotic is a live microorganism given in an amount that provides a health benefit. A postbiotic is a preparation of deliberately inactivated microorganisms, or their components, that provides a benefit. Akkermansia is sold both ways. Next-Microbiome formulas use postbiotic Akkermansia AH39, an inactivated preparation, so it is not counted or handled like a live culture.
-
Which exact strain or preparation it is. Probiotic effects are tied to specific strains. As NCCIH points out, if one Lactobacillus strain helps with a particular problem, that does not mean a different Lactobacillus would do the same. Akkermansia follows the same logic. Results from one preparation do not automatically carry over to another, which is why the evidence table further down names the exact preparation each study tested.
This also changes the usual worry about combining. Questions about whether two live strains compete for space do not translate directly to an inactivated ingredient. With postbiotic Akkermansia, the more useful questions are how much is in each serving, how it was prepared, and what else the product contains.
Do More Probiotic Strains or More Products Give Better Results?
Not reliably. A long strain list or a large CFU number can look like a sign of strength, but the evidence does not support reading it that way. The NIH Office of Dietary Supplements notes that products with higher CFU counts are not necessarily more effective than products with lower counts, and many probiotic supplements on the market have never been studied at all.
Each strain carries its own evidence, or its own lack of evidence. A ten-strain capsule is not five times stronger than a two-strain one. It is a different product with a different set of questions attached.
There is also a real difference between a formula built as one product and a combination you assemble at home. The scientists who wrote the international consensus definition of synbiotics concluded that a combination's benefit should be confirmed by testing the combination itself in the people it is meant for, because ingredients that work on their own may not behave the same way together. Two separate bottles taken side by side form a combination nobody has tested. That does not make it harmful. It means the result is unknown, and any ingredient the two labels share is simply being taken twice.
How Strong Is the Evidence for Combining Akkermansia With Other Probiotics?
Different kinds of evidence answer different questions. The table separates what is well documented from what has not been tested.
|
Type of evidence |
What it tells you |
What it cannot tell you |
Weight for this decision |
|---|---|---|---|
|
Human trials of specific Akkermansia preparations |
In a randomized, placebo-controlled pilot trial (40 adults enrolled, 32 completed), daily live or pasteurized A. muciniphila for three months was safe and well tolerated, and the pasteurized form improved insulin sensitivity and lowered insulin and total cholesterol compared with placebo (Depommier, 2019). A larger 2026 trial of pasteurized A. muciniphila MucT in 142 adults with metabolic syndrome did not meet its main insulin-sensitivity goal for the whole group, with some benefits seen in subgroups (Suenaert, 2026). |
Results for other strains or preparations, including AH39, or for Akkermansia taken together with another probiotic product. |
Meaningful for the preparation studied; limited beyond it |
|
European food-safety assessment |
The European Food Safety Authority concluded that one pasteurized A. muciniphila preparation is safe as a novel food for adults at the intake it assessed (EFSA, 2021). |
Effectiveness, use in children, other preparations, or combinations with other supplements. |
Strong, for a narrow safety question |
|
NIH guidance on probiotics in general |
General principles that apply to any probiotic product, including that effects are strain-specific and that some people face higher risk than others (NIH ODS; NCCIH). |
Whether a particular pair of products suits you. |
Strong, as general rules |
|
Supplement Facts panels and a manufacturer's certificate of analysis |
What each product declares per serving and, for a tested production lot, whether measured amounts and microbial tests met specifications. |
Whether the product works, or how two products behave when taken together. |
Strong, for composition only |
|
Studies of finished multi-strain formulas that include Akkermansia |
How that exact formula performed in the people who were studied. |
How a different formula, or a combination you assemble yourself, would perform. |
Specific to that formula |
|
Trials of two separately purchased products taken together |
None identified for Akkermansia Chewable, Boost Synergy, or either product combined with another brand's probiotic. |
Whether the pairing adds anything. A missing trial is not evidence of harm. |
No direct evidence |
What Should You Compare on Two Supplement Labels Besides the Probiotic Strains?
Most overlap sits outside the strain list. When you set two products side by side, read these parts of each label:
-
Live strains: the full name including the strain code (for example, Streptococcus salivarius K12), and the CFU count if one is given.
-
Postbiotics and inactivated microbes: usually listed by weight in milligrams, under names such as postbiotic Akkermansia or a branded postbiotic blend.
-
Fibers and prebiotic ingredients: acacia, inulin and similar fibers act as food for gut microbes rather than as microbes themselves, a distinction covered in the difference between prebiotics and probiotics. Two products can each add a little.
-
Botanicals and amino acids: extracts such as pomegranate, grape seed or ashwagandha, and amino acids such as L-theanine or glycine. These are active ingredients with their own considerations, separate from any probiotic question.
-
Other Ingredients: sweeteners, fillers and coatings. They are easy to skip, and they can matter if your digestion is sensitive.
-
Directions and warnings: serving size, whether to take the product with food, and any cautions printed on the label.
Akkermansia Chewable vs Boost Synergy: Which Ingredients Overlap?
Next-Microbiome's two Akkermansia products show how this works in practice. Amounts are per serving, as listed in the current Supplement Facts information for each product.
|
Ingredient |
Akkermansia Chewable (2 chewable tablets) |
Boost Synergy (2 capsules) |
|---|---|---|
|
Postbiotic Akkermansia muciniphila AH39 |
45 mg |
100 mg |
|
Keystone Postbiotic |
100 mg |
300 mg |
|
Acacia |
Acacia gum, 80 mg |
Organic acacia fiber (Inavea), 100 mg |
|
L-theanine |
75 mg |
50 mg |
|
Pomegranate |
Extract, 10 mg |
Fruit extract, 25 mg |
|
Live probiotic strains |
Streptococcus salivarius K12 (BLIS K12), 20 mg, 1 billion CFU |
Clostridium butyricum CCFM1299, Bifidobacterium lactis IDCC4301 and Bifidobacterium bifidum IDCC4201, in a 45 mg blend |
|
Other named ingredients |
Glycine 100 mg, blueberry powder 18 mg, elderberry extract 6 mg |
ButyraGen tributyrin complex 200 mg, grape seed extract 40 mg, ashwagandha 30 mg |
|
Sweeteners and other ingredients to note |
Mannitol, isomalt and xylitol |
See the current product label |
|
Bottle size |
60 tablets (30 servings) |
60 capsules (30 servings) |
Five ingredients appear in both formulas: postbiotic AH39, Keystone Postbiotic, acacia, L-theanine and pomegranate. The live strains do not overlap at all. The Chewable carries one oral strain, while Boost Synergy carries three different strains. Shared ingredients tell you where the formulas repeat each other. They do not signal an interaction, and the amounts are not meant to be added together into a daily target.
If you are choosing between the two, format and the rest of the formula are the practical differences. Akkermansia Chewable is a two-tablet chewable that pairs postbiotic AH39 with the live oral strain BLIS K12, which suits people who would rather not swallow capsules. Boost Synergy is a two-capsule formula with a larger amount of postbiotic AH39, three live strains, a tributyrin complex and several botanical extracts. Setting either label beside the products you already take is the most useful step before you decide.
How Do You Add Akkermansia to a Routine That Already Includes a Probiotic?
A short review before you buy prevents the most common problems, such as doubling ingredients or not knowing which product caused a change.
-
Name the reason. Decide what you want the new product to do that your current routine does not. If you cannot name one, a second product may not be worth adding.
-
List everything you take. Include probiotics, fiber powders, other supplements, and prescription or over-the-counter medicines.
-
Compare the current labels side by side. Use the Supplement Facts and Other Ingredients panels on the bottles in your hand rather than older product descriptions, and mark anything that appears twice.
-
Decide whether to add or replace. If a new formula already covers what your current probiotic does, replacing may be simpler than stacking. If a clinician recommended your current probiotic for a specific reason, ask before changing it.
-
Start one new product at a time. Keep the rest of your routine steady long enough to see how you feel before you change anything else.
-
Keep a brief note. Write down the start date, the product and any digestive changes. A simple record makes a conversation with a pharmacist or clinician far more useful.
You do not need to take two supplements at the same moment for either one to work, and there is no good evidence that doing so helps. Follow each label's directions and choose times you will actually keep. For morning versus evening and with-food questions, see our guide on when to take Akkermansia and why consistency matters.
Which Digestive Changes Are Common After Adding a Probiotic, and Which Need Medical Care?
Some people notice gas, bloating, a feeling of fullness or a change in bowel habits when they start a probiotic or add fermentable fiber. The NIH notes that in healthy people, probiotics may cause gas but rarely cause infections or other health problems. Digestive-health guidance from NIDDK adds that adding fiber gradually may help prevent gas and bloating. Starting two fiber-containing products in the same week can mean a bigger jump than either label suggests on its own.
These changes do not prove a supplement is working, and they are not a "detox." Mild symptoms that settle on their own can be noted and mentioned to a pharmacist or clinician if they linger. Symptoms that keep getting worse are a reason to stop the newest product rather than push through.
Stop the supplement and seek prompt medical care if you have:
-
Severe or worsening abdominal pain
-
Repeated vomiting
-
Blood in your stool, or black, tarry stools
-
A fever
-
Signs of dehydration, such as dizziness, very dark urine or passing little urine
Swelling of the face, lips or throat, or any difficulty breathing, needs emergency care.
Who Should Talk to a Clinician Before Combining Probiotic Supplements?
For most healthy adults, probiotics cause few side effects. The picture changes for people whose bodies are less able to contain a stray microbe. NCCIH notes that the risk of harmful effects is greater in people with severe illness or a weakened immune system, and the serious infections linked to probiotics have mostly involved people who were severely ill or immunocompromised.
Get individual advice before combining products if you:
-
Have a weakened immune system, including from chemotherapy, an organ transplant or immune-suppressing medicine
-
Have a serious or active illness, including active inflammatory bowel disease
-
Have had recent surgery or a hospital stay, or have a central venous catheter
-
Take several prescription medicines
The absence of a known interaction is not the same as proof that a combination is safe for you. Bring both labels to the appointment so your clinician can see exactly what is in each. For a closer look at what the research says about Akkermansia use over months and years, read our guide on whether Akkermansia is safe long term.
Akkermansia Combination Questions by Strain, Product and Health Situation
Can I take Akkermansia with a Lactobacillus or Bifidobacterium probiotic?
There is no general rule against it, and no general rule that the pairing works better. Lactobacillus and Bifidobacterium are the most researched probiotic groups, but their benefits belong to particular strains used for particular purposes, and that research does not tell you how a strain behaves next to an Akkermansia product. Choose each strain for a purpose its own evidence supports, and check that the two labels do not repeat the same fibers or extracts.
Can I take Akkermansia with Saccharomyces boulardii?
Usually this is a question of purpose rather than compatibility. S. boulardii is a probiotic yeast, not a bacterium, and it is one of the better-studied probiotics for specific situations, such as diarrhea linked to antibiotic use. Being a different type of organism does not make the pairing a problem, and it does not make the combination more effective. If a clinician suggested S. boulardii for a particular reason, keep to that plan and ask before adding anything.
If Boost Synergy already contains Akkermansia, do I need Akkermansia Chewable too?
Not necessarily. Both formulas already contain postbiotic Akkermansia AH39 and several other shared ingredients, so a second product mostly repeats the first. For most people, the one whose format and full formula fit their routine is enough on its own. If you are considering both for a specific reason, talk the plan through with a pharmacist or clinician before you start.
Can I add postbiotic milligrams to probiotic CFUs to compare two formulas?
No. The two numbers measure different things. Milligrams are weight. CFU, or colony-forming units, estimate how many live microbes in a serving are able to multiply. Under US rules, labels must list the total weight of the microorganisms, which can include dead cells, while CFU listing is voluntary. An inactivated postbiotic has no CFU count by design, so adding the figures together produces a total with no meaning. Compare live strains by name and CFU, and postbiotics by preparation and amount.
Could the sweeteners in a chewable probiotic affect my digestion?
For some people, yes. Many chewables are sweetened with sugar alcohols, also called polyols, and the Akkermansia Chewable lists mannitol, isomalt and xylitol among its other ingredients. A systematic review found that polyols can cause dose-dependent gas, abdominal discomfort and laxative effects in healthy people and in people with IBS, and that malabsorption increases when several polyols are eaten together. How much one serving affects you depends on your own sensitivity and on how many other sugar-free foods you have that day.
What should I ask my clinician if I am taking antibiotics and want to add a probiotic?
Ask whether a specific strain has evidence for your situation, whether it suits your medical history, and how to time it around your antibiotic doses. Research on preventing antibiotic-related diarrhea has looked closely at when a probiotic is started relative to the antibiotic, and the right plan depends on both the drug and the product. Never shorten, pause or skip an antibiotic course to make room for a supplement.
Can I take an Akkermansia supplement while using a prescription GLP-1 medication?
Ask your prescriber first. Dietary supplements, including those with GLP-1 in the product name, are not GLP-1 medicines and cannot replace semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound) or any other prescribed treatment. These medicines often cause digestive side effects of their own, so adding a new gut supplement can make it harder to tell what is behind a change. Bring the full label so your prescriber can review it alongside your treatment.
What if I have IBS and want to add Akkermansia to another gut supplement?
Get individual advice before stacking products. IBS triggers vary from person to person, and some ingredients common in gut supplements, such as added fibers and sugar alcohols, are the same ones IBS eating plans often adjust. A doctor may recommend more fiber or a low FODMAP diet depending on your symptoms, and any supplement needs to fit that plan rather than work against it. A gastroenterologist or registered dietitian can help you judge whether a product suits your current approach.
Can I combine Akkermansia and other probiotics while pregnant or breastfeeding?
Check with your obstetric provider or midwife before starting or combining these supplements. The main human Akkermansia trials were carried out in adults with excess weight or metabolic syndrome, not in pregnancy, so they cannot establish safety while pregnant or breastfeeding. Some gut formulas also contain botanicals, and NIH guidance notes that ashwagandha may not be safe for people who are pregnant or breastfeeding. Bring every label to the appointment.
Can children take an Akkermansia supplement together with another probiotic?
Only with guidance from the child's pediatrician. Adult supplements are formulated and labeled for adults, and both the human Akkermansia trials and the European safety assessment cover adults. A pediatrician can weigh age-specific evidence and decide whether any probiotic is appropriate for the child's situation.
Health Resources for Choosing and Using Probiotic Supplements
-
Probiotics: Fact Sheet for Consumers, NIH Office of Dietary Supplements. A plain-language explanation of what probiotic labels list and what research shows for common uses.
-
Probiotics: Usefulness and Safety, NIH National Center for Complementary and Integrative Health. Who faces greater risk from probiotics and what to raise with your provider.
-
Eating, Diet, and Nutrition for Irritable Bowel Syndrome, National Institute of Diabetes and Digestive and Kidney Diseases. Practical guidance on fiber and the low FODMAP diet for people with sensitive digestion.
These resources offer general information. Decisions about your own supplements and treatment belong with a qualified healthcare professional who knows your history.
Scientific References
-
Hill C, Guarner F, Reid G, et al.
Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic
Nature Reviews Gastroenterology and Hepatology 2014;11(8):506-514
doi:10.1038/nrgastro.2014.66 (Consensus statement) -
Salminen S, Collado MC, Endo A, et al.
The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics
Nature Reviews Gastroenterology and Hepatology 2021;18(9):649-667
doi:10.1038/s41575-021-00440-6 (Consensus statement) -
Swanson KS, Gibson GR, Hutkins R, et al.
The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics
Nature Reviews Gastroenterology and Hepatology 2020;17(11):687-701
doi:10.1038/s41575-020-0344-2 (Consensus statement) -
Cani PD, Depommier C, Derrien M, Everard A, de Vos WM.
Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms
Nature Reviews Gastroenterology and Hepatology 2022;19(10):625-637
doi:10.1038/s41575-022-00631-9 (Review) -
Depommier C, Everard A, Druart C, et al.
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
Nature Medicine 2019;25(7):1096-1103
doi:10.1038/s41591-019-0495-2 (Human randomized controlled pilot trial) -
Suenaert P, Segers A, Rymenans L, et al.
Effect of pasteurized Akkermansia muciniphila MucT on insulin sensitivity, body composition, and GLP-1 production in subjects with metabolic syndrome: impact of low baseline gut Akkermansia levels
Gut Microbes 2026;18(1):2690689
doi:10.1080/19490976.2026.2690689 (Human randomized controlled trial) -
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA).
Safety of pasteurised Akkermansia muciniphila as a novel food pursuant to Regulation (EU) 2015/2283
EFSA Journal 2021;19(9):6780
doi:10.2903/j.efsa.2021.6780 (Regulatory safety assessment) -
Lenhart A, Chey WD.
A systematic review of the effects of polyols on gastrointestinal health and irritable bowel syndrome
Advances in Nutrition 2017;8(4):587-596
doi:10.3945/an.117.015560 (Systematic review) -
NIH Office of Dietary Supplements
Probiotics: Fact Sheet for Health Professionals
Updated March 25, 2025 (Government guidance)
Written by Ali Rıza Akın
Microbiome Scientist, Author & Founder of Next-Microbiome
Ali Rıza Akın is a microbiome scientist with nearly 30 years of experience in translational biotechnology, systems biology, and applied microbiome research, spanning discovery, preclinical development, and clinical-stage translation.
His work focuses on how microbial ecosystems interact with human physiology, including:
-
Gut barrier function and intestinal permeability
-
Mucus-associated microbiota (Akkermansia-related systems)
-
Oral–gut microbiome axis
-
Short-chain fatty acids (SCFAs) and metabolic signaling
-
Circadian rhythm–microbiome interactions
Clinical Research Contributions:
He has contributed to multiple clinical-stage microbiome programs, supporting bacterial strain discovery, optimization, and formulation design across different therapeutic areas, including:
Active Ulcerative Colitis (Inflammatory Bowel Disease)
Hyperoxaluria (Oxalate Metabolism Disorder)
Microbiome-driven gut health and inflammatory conditions
These studies were part of broader clinical development programs evaluating microbiome-based approaches. His contributions focused on the early-stage scientific and translational pipeline, including strain discovery, functional optimization, and multi-strain formulation design.
Scientific Contributions:
Ali Rıza Akın is the discoverer of Christensenella californii, a bacterial species associated with microbiome diversity and metabolic health.
He is a contributing author to scientific publications and Bacterial Therapy of Cancer (Springer), and the author of Bakterin Kadar Yaşa: İçimizdeki Evren: Mikrobiyotamız.
Approach:
His work emphasizes evidence-based microbiome science, long-term safety, and a systems-based understanding of how microbes influence human health.
Review and Sources
This article was prepared from the peer-reviewed research and NIH guidance listed above, together with the current Supplement Facts information for each Next-Microbiome product. It is reviewed periodically as new research is published.
Medical Disclaimer
This content is for educational purposes only and is not medical advice. It is not intended to diagnose, treat, cure or prevent any disease. Statements about dietary supplements have not been evaluated by the US Food and Drug Administration, which does not review supplements before they are sold. Next-Microbiome products are intended for adults. Dietary supplements are not a substitute for prescription medication, including GLP-1 medicines such as Ozempic, Wegovy, Mounjaro or Zepbound. Talk with a qualified healthcare professional before starting, stopping or combining supplements, especially if you are pregnant or breastfeeding, managing a health condition, or taking medication.
Last reviewed: November 2026
